XWELL (NASDAQ:XWEL) Stock Price Down 1.9% – Here’s What Happened

XWELL, Inc. (NASDAQ:XWELGet Free Report) shares traded down 1.9% on Thursday . The company traded as low as $1.0450 and last traded at $1.05. 9,468 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 216,249 shares. The stock had previously closed at $1.07.

Analysts Set New Price Targets

A number of research firms recently weighed in on XWEL. Weiss Ratings cut shares of XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Wall Street Zen downgraded XWELL from a “hold” rating to a “sell” rating in a research report on Sunday, May 17th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

Check Out Our Latest Research Report on XWEL

XWELL Price Performance

The stock has a market cap of $8.86 million, a P/E ratio of -0.19 and a beta of 1.03. The stock’s 50-day moving average is $1.17 and its two-hundred day moving average is $1.02.

XWELL (NASDAQ:XWELGet Free Report) last announced its quarterly earnings results on Wednesday, May 20th. The company reported ($1.51) EPS for the quarter, missing the consensus estimate of ($1.00) by ($0.51). The company had revenue of $6.64 million during the quarter, compared to analysts’ expectations of $2.37 million. XWELL had a negative return on equity of 2,318.99% and a negative net margin of 81.43%.

XWELL Company Profile

(Get Free Report)

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.

See Also

Receive News & Ratings for XWELL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XWELL and related companies with MarketBeat.com's FREE daily email newsletter.